1. Chalmers, Samantha A, Ayilam Ramachandran, Rajalakshmy, Garcia, Sayra J, Mohan, Chandra, Putterman, Chaim. . The CD6/ALCAM pathway promotes lupus nephritis via T cell-mediated responses. In The Journal of clinical investigation, 132, . doi:10.1172/JCI147334. https://pubmed.ncbi.nlm.nih.gov/34981775/
2. Ferragut, Fátima, Vachetta, Vanina S, Troncoso, María F, Rabinovich, Gabriel A, Elola, María T. 2021. ALCAM/CD166: A pleiotropic mediator of cell adhesion, stemness and cancer progression. In Cytokine & growth factor reviews, 61, 27-37. doi:10.1016/j.cytogfr.2021.07.001. https://pubmed.ncbi.nlm.nih.gov/34272152/
3. Weidle, Ulrich H, Eggle, Daniela, Klostermann, Stefan, Swart, Guido W M. . ALCAM/CD166: cancer-related issues. In Cancer genomics & proteomics, 7, 231-43. doi:. https://pubmed.ncbi.nlm.nih.gov/20952758/
4. Luo, Hongmei, Zhang, Dan, Wang, Fangfang, Yi, Qing, Zheng, Yuhuan. . ALCAM-EGFR interaction regulates myelomagenesis. In Blood advances, 5, 5269-5282. doi:10.1182/bloodadvances.2021004695. https://pubmed.ncbi.nlm.nih.gov/34592762/
5. Jamann, Hélène, Desu, Haritha L, Cui, Qiao-Ling, Antel, Jack, Larochelle, Catherine. . ALCAM on human oligodendrocytes mediates CD4 T cell adhesion. In Brain : a journal of neurology, 147, 147-162. doi:10.1093/brain/awad286. https://pubmed.ncbi.nlm.nih.gov/37640028/
6. Chen, Jian, Dai, An-Xiang, Tang, Hai-Liang, Zeng, Xin, Wei, Nai-Li. 2023. Increase of ALCAM and VCAM-1 in the plasma predicts the Alzheimer's disease. In Frontiers in immunology, 13, 1097409. doi:10.3389/fimmu.2022.1097409. https://pubmed.ncbi.nlm.nih.gov/36685605/